Screener
Eligibility screening
A First-in-human Study of IMP1734 in Participants With Advanced Solid Tumors
23 US sites in AR, AZ, CA, CO +12
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
A First-in-human Study of IMP1734 in Participants With Advanced Solid Tumors
23 US sites in AR, AZ, CA, CO +12
Before we begin
Your answer affects how the questions are phrased.